Business / Finance

RSS

Grunenthal to commercialize Horizon Pharma's DUEXIS in Latin America

Horizon Pharma, Inc. a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases, today announced that it entered into an exclusive agreement with Grunenthal for the commercialization of DUEXIS in Latin America.

19 Jun 2012

ASI completes $5.3 million Series A Preferred Stock financing

Ablative Solutions, Inc. (ASI), a privately-held company headquartered in Kalamazoo, MI with offices in Menlo Park, CA announced today that it has completed a Series A Preferred Stock financing, totaling approximately $5.3 million (including the conversion of the bridge financing completed earlier this year), to fund its unique technology platform.

19 Jun 2012

Vetter prepares new filling line for syringes at Ravensburg location

The demand for prefilled syringes is on the rise and Vetter is prepared. The company, a leading contract development and manufacturing organization is building a state-of-the-art, high-performance filling line for syringes at its Ravensburg Vetter South location.

19 Jun 2012

Global market for wound closures to grow at 4.3% CAGR to reach $15.2 billion in 2016

As the worldwide economy recovers from recession into a new period of growth there is little doubt these developments will have a positive effect on the healthcare technologies market, including the multi-billion dollar Wound Management segment.

18 Jun 2012

Key health law official leaving post for UnitedHealth VP job

Steve Larsen, director of the federal Center for Consumer Information and Insurance Oversight, is leaving his post to join UnitedHealth as an executive vice president, sparking speculation on the move.

18 Jun 2012

FDA grants Cook Pharmica first commercial manufacturing approval

In a decision that paves the way for greater pharmaceutical industry use of the company's contract manufacturing services, Cook Pharmica LLC has received its first approval from the U.S. Food and Drug Administration (FDA) to manufacture commercial product.

18 Jun 2012

MMRGlobal, Fujitsu collaborate to offer cost-effective transition to electronic medical records

MMRGlobal, Inc. and Fujitsu Computer Products of America, Inc., the market leader in document imaging scanners, announced today a strategic alignment to assist physicians in smaller practices to efficiently digitize their medical records and comply with the Health Information Technology for Economic and Clinical Health (HITECH) Act's meaningful use requirement to provide patients timely online access to their medical records by the end of 2014.

18 Jun 2012

Dehaier, Heyer enter into three-year strategic mutual cooperation agreement

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that the Company has entered into a three-year strategic mutual cooperation agreement with HEYER Medical AG, an internationally recognized, Germany-based company specializing in state-of-the-art inhalation and anesthesia equipment, oxygen concentrators, breathing therapy equipment and connecting equipment.

18 Jun 2012

Concord Medical acquires 52% equity ownership in Chang'an Hospital

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, announced today that it has closed the acquisition of 52% equity ownership in Chang'an Hospital, a leading non-public general hospital located in Xi'an, Shaanxi Province.

18 Jun 2012

CMC Biologics' Bothell manufacturing and testing facilities receive cGMP compliance

CMC Biologics, a leading contract manufacturing organization (CMO) known for its technical excellence in process development and cGMP manufacture, has received a Certificate of Good Manufacturing Practice (GMP) Compliance for commercial manufacturing issued by the Medicines and Healthcare products Regulatory Agency (MHRA).

18 Jun 2012

Quintiles announces agreements to expand lab testing capabilities in China

In a ceremony underscoring the growing importance of China to the global biopharmaceutical industry, Quintiles executives and local dignitaries today announced agreements to establish a Quintiles regional headquarters for China in Shanghai and to significantly expand lab testing capabilities in China.

18 Jun 2012

Bruker inaugurates new applications and customer support Center of Excellence in Moscow

Bruker marks another milestone in its more than 40 year history in Russia, with today's grand opening of its new applications and customer support Center of Excellence in Moscow.

15 Jun 2012

SQI raises CDN $754,000 in third and final tranche of private placement

SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, announced today it has raised gross proceeds of CDN $754,000 from the closing of the third and final tranche of a non-brokered private placement of 430,713 units priced at $1.75 per Unit.

15 Jun 2012

Axial Exchange announces acquisition of mRemedy

Axial Exchange Inc. today announced that Axial Exchange has acquired mRemedy, a company formed in 2009 by DoApp, Inc. and Mayo Clinic to offer a mobile healthcare platform to healthcare providers.

15 Jun 2012

Third Rock Ventures announces formation of Global Blood Therapeutics

Third Rock Ventures, LLC today announced the formation of Global Blood Therapeutics, Inc. and its $40.7 million Series A financing of the company.

15 Jun 2012

CryoLife reaches full settlement in Medafor lawsuit

CryoLife, Inc., a leading medical device company focused on cardiac and vascular surgery, announced today that it has reached full settlement of the outstanding CryoLife, Inc. v. Medafor, Inc. lawsuit that was pending in the Northern District Court of Georgia.

15 Jun 2012

Johnson & Johnson acquires Synthes

Johnson & Johnson today announced the completion of the acquisition of Synthes, Inc. for a total purchase price of $19.7 billion in cash and stock. Synthes will now be integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson & Johnson.

15 Jun 2012

Invuity closes $25M Series D round of financing

Invuity, a leading developer of state-of-the-art surgical visualization and illumination technology, has raised a $25 million Series D round of financing to expand the development, manufacturing and commercialization of the company's advanced medical devices.

14 Jun 2012

Medical Action fourth quarter net sales increase 3% to $108.2 million

Medical Action Industries Inc., a leading supplier of medical and surgical disposable products, today reported results for the fourth quarter and fiscal year ended March 31, 2012.

14 Jun 2012

UHCO alumnus donate $5 million to University of Houston

University of Houston College of Optometry (UHCO) alumnus Dr. Doug Barnes and his wife, Molly, have made a $5 million pledge to the University of Houston. The gift will be submitted for state matching funds through the Texas Research Incentive Program.

14 Jun 2012